Should You Be Tested or Treated for Ureaplasma parvum?
No, you should not be tested or treated for Ureaplasma parvum as an asymptomatic contact of someone who tested positive. Routine testing and treatment of asymptomatic individuals for U. parvum is not recommended and may cause more harm than good through unnecessary antibiotic exposure and selection of antimicrobial resistance 1.
Why Testing and Treatment Are Not Recommended
The European STI Guidelines Editorial Board explicitly states that routine testing and treatment of asymptomatic men and women for U. parvum are not recommended because:
- Asymptomatic carriage is extremely common in sexually active individuals, with colonization rates ranging from 40-80% in some populations 1
- The majority of colonized individuals never develop any disease 1
- There is no evidence that detecting and treating U. parvum colonization does more good than harm 1
U. parvum is considered a commensal organism (normal inhabitant) of the urogenital tract rather than a true sexually transmitted infection 1, 2. Multiple high-quality studies demonstrate that U. parvum is not associated with specific genital symptoms or clinical signs in nonpregnant women 2.
The Problem with Widespread Testing
The commercialization of multiplex PCR assays that detect U. parvum alongside true STIs has created a problematic situation:
- Extensive testing and subsequent treatment may select for antimicrobial resistance in these bacteria, in true STI agents, and in the general microbiota 1
- This creates substantial economic costs for society and individuals, particularly women 1
- Testing leads to overdiagnosis and overtreatment without clear clinical benefit 3
What You Should Do Instead
Focus on testing for true sexually transmitted infections rather than U. parvum:
- If you have any urogenital symptoms, you should be tested for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis 1
- These are the organisms that require detection and treatment, not U. parvum 1
- Routine sexual health screening should focus on these established STIs, not commensal organisms 4
When U. parvum Testing Might Be Considered (Not Your Situation)
Testing for Ureaplasma species should only be considered in very specific circumstances that do not apply to you:
- Men with symptomatic urethritis who have tested negative for N. gonorrhoeae, C. trachomatis, M. genitalium, and T. vaginalis, AND only if quantitative species-specific testing shows high U. urealyticum (not U. parvum) load 1
- Symptomatic women should first be evaluated and treated for bacterial vaginosis if present 1
- Pregnancy-related complications in specific clinical contexts 5
Note that even in symptomatic men, only U. urealyticum at high bacterial loads is potentially pathogenic—U. parvum remains non-pathogenic even in symptomatic individuals 1, 6.
Critical Distinction: U. parvum vs. U. urealyticum
Your relative tested positive for U. parvum specifically, which is important because:
- U. parvum accounts for approximately 92.6% of Ureaplasma isolates 7
- U. parvum has not been associated with urethritis or other genital symptoms, even in symptomatic patients 1, 2
- Only U. urealyticum (the less common species) has any potential pathogenic role, and only at high bacterial loads 1, 6
Partner Notification Guidelines
Standard STI partner notification guidelines do not apply to U. parvum:
- Partner referral is recommended for true STIs like gonorrhea and chlamydia 4
- U. parvum is not classified as a true STI requiring partner notification or treatment 1
- Your relative's positive test does not create an obligation for you to be tested or treated 1
Common Pitfall to Avoid
Do not confuse U. parvum with established STIs like Chlamydia trachomatis or Mycoplasma genitalium. The inclusion of U. parvum in commercial multiplex STI panels has led many clinicians and patients to mistakenly believe it requires the same approach as true STIs, but the evidence clearly shows this is not the case 1, 2.